$ALTO Balance Sheet | Understand Stock

$ALTO

$3.66 +$0.05 (1.39%) Close

$ALTO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current Assets:
Cash and cash equivalents
Restricted cash

Accounts receivable, net (net of allowance for doubtful accounts of $135 and $378, respectively)
Accounts receivable (net of allowance for credit losses of $38 and $76, respectively)
Inventories
Prepaid inventory
Transferable tax credits, net
Derivative instruments
Notes receivable, current
Other current assets
Total current assets
Property and equipment, net
Right of use operating lease assets, net
Notes receivable, noncurrent
Intangible assets, net
Other Assets:
Right of use operating lease assets, net
Intangible assets, net
Goodwill
Other assets
Total other assets
Total Assets
Current Liabilities:
Accounts payable
Accrued liabilities
Current portion – long-term debt
Current portion – operating leases
Derivative instruments
Liabilities held-for-sale
Other current liabilities

Total current liabilities
Long-term debt, net
Operating leases, net of current portion
Other liabilities
Total Liabilities
Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2026 and December 31, 2025; liquidation preference of $18,075 as of June 30, 2026
Series B Preferred Stock
Total preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2026 and December 31, 2025; liquidation preference of $18,075 as of June 30, 2026
Common stock, value
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total Stockholders’ Equity

Total Stockholders’ Equity
Total Liabilities and Stockholders’ Equity

Comments